Login
Toggle navigation
Videos
Categories
Trending
Mr. CEO Unveils Embraer's New Turboprop with 250+ LOIs | Arjan Meijer - CEO of Embraer
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Arjan Meijer is Pres/CEO:Commercial Aviation at Embraer SA.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Greg Silver Discusses Diversification and Growth in Experiential Real Estate Ventures | Greg Silvers , CEO,EPR Properties.
00:10:00
Chairman and CEO of Iwatani Corporation, Mr. Akiji Makino, attends the 4th Hydrogen Energy Ministerial Meeting.
00:10:00
ABN AMRO CEO Robert Shaak on Collective Responsibility for Sustainability|Robert Swaak, CEO , ABN AMRO.
00:00:00
Interested in the development and characterization of animal models of human neurodegenerative diseases / Matthew Frosch, M.D., Ph.D.
00:10:00
solve problems and multiply the benefits of capitalism for everyone while reducing its cost|Dr. Kiersten Stead,Managing Partner, DCVC Bio,DCVC
00:10:00
Personalized Financial Guidance: Local, Fiduciary, and Holistic Support
00:00:00
Lisa M. Rimsza, M.D. Pathologist, Mayo Clinic
00:10:00
Clarent Precision: The Key to Success in Quality Machining and Customer Satisfaction
00:10:00
Overview of Family Investment Center's Unique Approach to Investment Management
00:10:00
Exploring St. Augustine's Enduring Influence: Insights from Professor Paig Hawk Child|Paige Hochschild,Professor,Mount St. Mary's University
00:10:00
James Fisher & Sons plc Showcases Innovative Solutions at SPE Offshore Europe 2019 | Jean Vernet - Chief Executive Officer of James Fisher and Sons plc
00:10:00
David Berlinski on Scientific Overreach and the Myth of Global Warming